When it comes to medical science and technology issues such as organ reconstruction and incurable diseases treatment, do you think of futuristic medical movies in Hollywood or laboratory technology in the West and even Japan first? In fact, you may have underestimated the strength of stem cells in Taiwan Province Province. In fact, with its strong medical strength and R&D energy, even under the escort of patents and regulations, the stem cell industry in Taiwan Province Province has always been a promising star in the world.

Huang, the first person in the world who published papers and patents on the successful isolation and identification of amniotic fluid stem cells, is the "godfather of amniotic fluid stem cells in Taiwan Province Province", an authority on stem cell research and preservation, a microbiologist and a doctor of molecular genetics at Rutgers University in the United States, and a key figure in letting the world see stem cell technology in Taiwan Province Province. The collection technology of amniotic fluid stem cells invented by him is still the standard used by laboratories all over the world.

Stem cells are the key technology of future medicine. What is "stem cell"? This problem should start with regenerative medicine. With the development of medical technology, it is difficult to break through the challenge of organ regeneration. However, Huang pointed out that "stem cells" are the original undifferentiated cells of the human body, which can divide and proliferate themselves and differentiate into a variety of cells with different specific functions. If the technology is in place, this primitive cell with the ability of "regeneration" and "differentiation" will be used to regenerate human tissues, such as specific cell types and even human organs.

People often heard about "embryonic stem cells" in the past, but embryonic stem cells are taken from the fetus, which has ethical doubts. Therefore, in the field of international scientific research and application, people generally turn their attention to more conservative and safe umbilical cord blood stem cells, and many related manufacturers in China are committed to extracting and storing umbilical cord blood stem cells from infants.

Amniotic fluid stem cells have the advantages of all kinds of stem cells and will become a prominent school in the future. However, there is a gap of 10 months between embryonic stem cells and umbilical cord blood stem cells. During this period, stem cell technology was once a blind spot in the research field, until Huang used special technology to extract amniotic fluid stem cells which were more widely used than umbilical cord blood stem cells.

Amniotic fluid stem cells are very close to embryonic stem cells in development and function, and they all have the ability to differentiate into various tissue cells. Up to now, amniotic fluid stem cells are recognized by the scientific community as one of the most promising cell sources for clinical application and tissue engineering.

According to Huang's analysis, amniotic fluid stem cells have the differentiation potential between embryonic stem cells and adult stem cells, and combine their advantages. At present, the research and application of amniotic fluid stem cells in the world include stroke, Parkinson's disease, myocardial infarction, pulmonary fibrosis, acute renal failure, urinary incontinence and bone repair. Stem cells have a wide range of applications.

"Amniotic fluid stem cells are early fetal cells, and the telomere length of chromosomes is very long, which means that cells have better proliferation and growth ability than those after birth, and the aging speed is slower," Huang said.

He also pointed out that saving more amniotic fluid during prenatal examination is not only for taking care of children, but also for taking care of family members, because the immune antigenicity of amniotic fluid stem cells is very low, and families with similar blood ties will have the opportunity to provide different medical care in the future.